作者：
Sabloff,M. [1]
;
Sobecks,R.M. [2]
;
Ahn,K.W. [3]
;
Zhu,X. [4]
;
deLima,M. [5]
;
Brown,J.R. [6]
;
Inamoto,Y. [7]
;
Holland,H.K. [8]
;
Aljurf,M.D. [9]
;
Laughlin,M.J. [10]
;
Kamble,R.T. [11]
;
Hsu,J.W. [12]
;
Wirk,B.M. [13]
;
Seftel,M. [14]
;
Lewis,I.D. [15]
;
Arora,M. [16]
;
Alyea,E.P. [17]
;
Kalaycio,M.E. [18]
;
Cortes,J. [19]
;
Maziarz,R.T. ;
Gale,R.P. ;
Saber,W.
作者单位：
Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic Foundation, Cleveland, OH
[1]
Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, United States
[2]
Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin
[3]
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
[4]
Division of Oncology and Hematology, The Blood and Marrow Transplant Program at Northside Hospital
[5]
Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia
[6]
Division of Hematologic Malignancies and Stem Cell Transplantation, Seidman Cancer Center
[7]
Division of Hematology, Department of Medicine, University of Ottawa and The Ottawa Hospital
[8]
Hematopoietic Cell Transplantation Program, University Hospitals Case Medical Center, University of
[9]
Division of Hematology and Oncology, Baylor College of Medicine Center for Cell and Gene Therapy
[10]
Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States
[11]
Section of Hematology, Division of Experimental Medicine, Department of Medicine, Imperial College
[12]
Division of Hematology, Oncology and Transplant, University of Minnesota Medical Center, Fairview
[13]
Center for Hematologic Malignancies, OHSU Knight Cancer Institute, Oregon Health and Science
[14]
Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital, Adelaide, SA, Australia
[15]
Division of Hematology and Oncology, Stony Brook University Medical Center, Stony Brook, NY, United
[16]
Division of Hematology and Oncology, Department of Medicine, Shands Healthcare and University of
[17]
Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA, United States
[18]
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[19]
发布时间
2015-03-11
换一批
